HAEMATO AG (XTER:HAEK) Days Payable : 25.85 (As of Jun. 2023)

View and export this data going back to 2005. Start your Free Trial

What is HAEMATO AG Days Payable?

HAEMATO AG's average Accounts Payable for the six months ended in Jun. 2023 was €17.5 Mil. HAEMATO AG's Cost of Goods Sold for the six months ended in Jun. 2023 was €123.4 Mil. Hence, HAEMATO AG's Days Payable for the six months ended in Jun. 2023 was 25.85.

The historical rank and industry rank for HAEMATO AG's Days Payable or its related term are showing as below:

XTER:HAEK' s Days Payable Range Over the Past 10 Years
Min: 8.34 Med: 12.58 Max: 27.83
Current: 23.56

During the past 13 years, HAEMATO AG's highest Days Payable was 27.83. The lowest was 8.34. And the median was 12.58.

XTER:HAEK's Days Payable is ranked worse than
93.46% of 978 companies
in the Drug Manufacturers industry
Industry Median: 86.975 vs XTER:HAEK: 23.56

HAEMATO AG's Days Payable increased from Jun. 2022 (20.08) to Jun. 2023 (25.85). It may suggest that HAEMATO AG delayed paying its suppliers.

HAEMATO AG Days Payable Historical Data

The historical data trend for HAEMATO AG's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HAEMATO AG Days Payable Chart

HAEMATO AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Payable

Get a 7-Day Free Trial

11.54

27.83

27.01

18.12

21.71

HAEMATO AG Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Days Payable	Get a 7-Day Free Trial															19.30	21.03	20.08	20.51	25.85

Competitive Comparison of HAEMATO AG's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, HAEMATO AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HAEMATO AG's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HAEMATO AG's Days Payable distribution charts can be found below:

* The bar in red indicates where HAEMATO AG's Days Payable falls into.

HAEMATO AG Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

HAEMATO AG's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (12.224	+	14.724)	/	2 )	/	226.535	*	365
=	13.474					/	226.535	*	365
=	21.71

HAEMATO AG's Days Payable for the quarter that ended in Jun. 2023 is calculated as:

	Days Payable (Q: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2022 )	+	Accounts Payable (Q: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
=	( (14.724	+	20.232)	/	2 )	/	123.395	*	365 / 2
=	17.478					/	123.395	*	365 / 2
=	25.85

HAEMATO AG Days Payable Related Terms

Thank you for viewing the detailed overview of HAEMATO AG's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

HAEMATO AG (XTER:HAEK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HAEMATO AG (XTER:HAEK) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

HAEK:Germany HAEK:Germany HAEK:Germany

Address

Lilienthalstrasse 5c, Schonefeld, DEU, D-12529

Website

https://www.haemato.ag

HAEMATO AG is a Germany based pharmaceutical company. It provides pharmaceuticals for the care of chronically ill people. The firm is engaged in the sale of generic and EU (European countries) import drugs. It is focused on patented and non-patented medicinal products. The company product portfolio includes human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), neurology, oncology, rheumatology, and urology. Geographically, it operates only in Germany.

HAEMATO AG (XTER:HAEK) Headlines

No Headlines